| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.08B | +7.9% |
| Gross profit | $0.74B | — |
| Operating income | $-0.03B | — |
| Net income | $-0.08B | -188.8% |
| Gross margin | 68.0% | Net margin -7.2% |
| Revenue Q/Q | +5.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| Toric And Multifocal | $0.36B | 33.7% |
| Sphere Other | $0.36B | 33.2% |
| Office And Surgical | $0.21B | 19.8% |
| Fertility | $0.14B | 13.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.35B | 32.0% |
| R&D | $0.04B | 3.9% |
| SG&A | $0.68B | 62.5% |
| Tax & other | $0.05B | 4.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CPRT ・ GLW ・ CPAY ・ CTVA ・ CSGP ・ COST ・ CRH ・ CRWD ・ CCI ・ CSX ・ CMI ・ CVS
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies